title: Late-onset epilepsy in children with acute febrile encephalopathy with prolonged convulsions: A clinical and encephalographic study.
abstract: The aim of this study is to analyze the characteristics of epilepsies as the sequelae of acute febrile encephalopathy with prolonged convulsions during childhood. Sixteen patients (M:F=9:7) aged 2-13years (mean 6.1years) with history of febrile acute encephalopathy were retrospectively reviewed. These patients experienced febrile encephalopathy at the age of 11months to 4years, with 11 individuals presenting with findings of a biphasic clinical course (n=5), frontal predominant (n=8) lesions, and/or reduced diffusivity in the cerebral white matter on magnetic resonance imaging (MRI; n=3). The remaining 5 patients had unilateral lesions that manifested the phenotype of hemiconvulsion-hemiplegia-epilepsy syndrome (HHES). Epilepsy emerged with a latent period of 2months to 2years after the acute phase of febrile encephalopathy. Head nodding or spasm with subsequent motion arrest and brief tonic seizures were the main seizure phenotypes. Ictal records of epileptic seizures were available in 9 patients. Epileptiform discharges with a focal or uneven distribution appeared at the seizure onset and lasted less than 1s in all patients; these were followed by either generalized attenuation or fast activity in 8 patients with head nodding, spasm, or brief tonic seizures, and by localized fast activity in 1 patient with versive tonic seizures. Notably, the seizure onset area was often located outside the severe lesions on MRI, i.e., in the parietal areas in patients with frontal predominant lesions, and in the spared hemisphere of HHES. Although phenobarbital, zonisamide, carbamazepine, clobazam, clonazepam, and clorazepate were partially effective in some patients, daily seizures persisted in 11 patients. Callosotomy was performed in 2 patients, and beneficial effects were observed in both. These characteristics suggested a broad distribution of augmented excitability in these patients, resulting in the rapid propagation of epileptic activity in the initial phase of ictal phenomena. Thus, this study investigates the most severe subgroup of epilepsy following febrile acute encephalopathy and provides the basis for further exploration of the pathogenesis and treatment of characteristic seizures in this population.
authors.affiliation: Department of Child Neurology, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan. stakashi@ncnp.go.jp
authors.forename: Takashi
authors.initials: T
authors.lastname: Saito
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Saito
authors.forename: Kenji
authors.initials: K
authors.lastname: Sugai
authors.forename: Eiji
authors.initials: E
authors.lastname: Nakagawa
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Komaki
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Okazaki
authors.forename: Yusaku
authors.initials: Y
authors.lastname: Ishido
authors.forename: Yuu
authors.initials: Y
authors.lastname: Kaneko
authors.forename: Takanobu
authors.initials: T
authors.lastname: Kaido
authors.forename: Akio
authors.initials: A
authors.lastname: Takahashi
authors.forename: Taisuke
authors.initials: T
authors.lastname: Ohtsuki
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Sakuma
authors.forename: Masayuki
authors.initials: M
authors.lastname: Sasaki
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004569:Electroencephalography; D004827:Epilepsy / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005625:Frontal Lobe / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D008607:Intellectual Disability / Q000150:complications* / Q000188:drug therapy; D065768:Lennox Gastaut Syndrome; D008279:Magnetic Resonance Imaging; D015225:Magnetoencephalography; D008297:Male; D012189:Retrospective Studies; D003294:Seizures, Febrile / Q000150:complications* / Q000188:drug therapy; D013036:Spasms, Infantile / Q000150:complications* / Q000188:drug therapy
chemical_list: D000927:Anticonvulsants